|
Christine, I participated in the Phase I-II Combination Immunotherapy Intracellular Domain (ICD) Peptide-Based Vaccine at University of Washington/Seattle which allowed concurrent Herceptin while receiving 6 vaccine injections over 6 months, receiving the first vaccine in January of 2005 and the last one in June 2005. In October of 2005 I was diagnosed with a recurrence to the right axilla nodes; pathology of the fine needle biopsy confirmed Her-2 neu+++, ER/PR-, the same as primary bc. After 6 months of Navelbine/Herceptin, and now into 5th month of Xeloda/Herceptin with little change my med onc recommended radiation to the right axilla as the primary bc was on the left side and I've never had rads to the right. I had the 4th treatment of 33 today. My rad onc feels we have a good shot at eliminating this problem area...
Hope to then qualify for another trial at UW/Seattle!
<3 Lolly
|